Colgate-Palmolive's 130-Year Dividend Meets a Shrinking Home Market

Colgate-Palmolive has paid an uninterrupted dividend since 1895, a 130-year streak that now sits against a shrinking North American business and a premium valuation, with the shares last closing at 86.06, up 0.87% on the day.

A dividend that has been paid every year since 1895 is not a marketing line. It is a record that survived two world wars, the Depression, the inflation of the 1970s, the 2008 credit freeze and the pandemic. Colgate-Palmolive (ticker: CL) has sent cash to shareholders continuously for 130 years, beginning during Grover Cleveland's second term in the White House.

The question investors are asking in 2026 is narrower and less romantic: does that record justify what the shares cost today, when the company's North American business is shrinking and the stock still trades at a premium to the broad market?

What the tape says right now

Colgate-Palmolive shares last changed hands at 86.06, up 0.87% from the prior close of 85.32, with a session range of 85.05 to 86.14, as of the last trade on Friday, 25 September 2026. That was a firm day but not a standout one. The Dow 30, tracked by DIA, closed at $517.49, up 0.94%; the S&P 500, via SPY, closed at $771.35, up 0.54%; and the Nasdaq 100 proxy QQQ finished at $744.50, up 0.46%. Colgate's move landed between the two, beating the S&P 500 by roughly a third of a percentage point on the day and trailing the Dow slightly.

A single session tells you nothing about a 130-year dividend. But it does tell you something about positioning: a defensive consumer staples name keeping pace with a broad tape that is itself advancing is not a market treating staples as a hiding place. It is a market pricing them like anything else.

Why the streak is a weaker argument than it looks

Dividend longevity is a signal about the past. It says management has been unwilling to break a promise, that the board has treated the payout as close to sacred, and that the underlying business has thrown off cash reliably enough to fund it through every macro regime since the nineteenth century. Those are real attributes. They are also, in an important sense, backward-looking.

What a streak does not tell you is what you are paying for the next decade of that cash. The dividend record is fixed history; the price is a live variable, reset every session. Two investors can own the same streak and earn wildly different returns depending on the multiple at which they bought in. This is the tension the record obscures — and it is the tension 24/7 Wall St put at the center of its look at the company.

There is a second, subtler problem. A long, unbroken payout history creates its own constituency. Income funds, dividend-focused ETFs and retail holders buy the name partly because of the streak, which supports the share price somewhat independently of business momentum. That support is a feature when fundamentals are stable. It becomes a risk when they are not, because the valuation can stay elevated longer than the operating results warrant, leaving a wider gap to close when reality reasserts itself.

The North American problem

The uncomfortable fact underneath the streak is that Colgate-Palmolive's North American business is shrinking. For a company whose products sit in nearly every bathroom cabinet in the country, that is not a demand cycle — it is a structural challenge.

Consumer staples in developed markets have spent several years pulling the same lever: price. Unit volumes were flat or falling, and revenue growth came from charging more for the same tube of toothpaste or bottle of dish soap. That lever has limits. Shoppers trade down to private label, retailers push back on cost increases, and eventually the arithmetic stops working. When a home market stops growing, the burden shifts entirely onto emerging markets, cost discipline and buybacks to deliver earnings growth — and each of those is a harder, less predictable lever than a price increase in a category consumers buy on autopilot.

For dividend investors, the relevant chain is straightforward. Payouts are funded by free cash flow. Free cash flow comes from earnings and working capital discipline. Earnings, over time, come from volume and price. If the largest, highest-margin region is contracting in volume terms, the dividend is not immediately at risk — a 130-year commitment does not get abandoned quickly — but the growth of the dividend is under pressure, and dividend growth is most of what a long-term income investor is actually buying.

What a premium multiple demands in return

Paying a premium valuation is a bet that the business will deliver above-average, above-certainty results. In staples, the premium has historically been paid for exactly that certainty: brands with pricing power, categories that do not disappear in a recession, and cash conversion that holds up when cyclicals crack.

The trouble arises when the premium persists while the certainty erodes. A rich multiple leaves almost no room for error. A single quarter of volume declines, an unfavorable currency swing in the emerging markets that now carry the growth story, or a margin squeeze from input costs can all trigger a derating — and a derating on a high multiple hurts far more than the dividend pays in a year.

That is the honest way to frame the decision. The streak and the valuation are not two separate facts. They are the same fact viewed from different ends: the market has already priced the reliability, so the buyer today is not being compensated for it.

What to watch from here

• Organic volume in North America. The distinction between price-led growth and volume-led growth is the single most useful line in the earnings release. Volume stabilizing would change the story materially.
• Dividend growth rate versus the dividend itself. The payout is very likely safe. Whether it grows faster than inflation is the live question, and it is the one that determines real returns.
• Emerging market contribution. With the home market contracting, the international mix has to do more work — and carries more currency and political risk.
• The multiple relative to staples peers. A premium can be justified. It has to be re-earned each reporting period.

None of this argues that Colgate-Palmolive is a bad company or that the dividend is in jeopardy. It argues something more specific: that 1895 is a wonderful date and a poor valuation input. The streak tells you the company will almost certainly pay you. It does not tell you what that payment is worth at 86.06 a share.

Key facts

• Ticker and last close: CL — 86.06, +0.87%, as of 25 Sep 2026 20:00 GMT (market closed)
• Dividend streak: Paid without interruption since 1895 — 130 years
• Session range: 85.05 – 86.14, prior close 85.32
• Benchmark comparison: S&P 500 (SPY) $771.35 +0.54%; Dow 30 (DIA) $517.49 +0.94%

Frequently asked questions

How long has Colgate-Palmolive paid a dividend?

Colgate-Palmolive has paid a dividend without interruption since 1895, a streak of 130 years that began during Grover Cleveland's second term as president. The payout has continued through every major economic disruption since, including two world wars, the Great Depression, the inflationary 1970s and the 2008 financial crisis.

Where did Colgate-Palmolive shares last close?

Colgate-Palmolive last traded at 86.06, up 0.87% from a prior close of 85.32, with a session range of 85.05 to 86.14. That was the last trade as of Friday, 25 September 2026 at 20:00 GMT. Markets were closed at the time of writing, so this is the most recent close rather than a live price.

What is the main concern about the business?

The company's North American business is shrinking. Because North America is a large and historically high-margin region for the company, contraction there shifts the burden of earnings growth onto emerging markets, cost discipline and buybacks. That makes future results less predictable than the dividend record alone would suggest.

Does a long dividend streak make a stock safe?

A long streak indicates management's commitment and the durability of cash flows in the past, but it says nothing about the price you pay today. Returns depend on the valuation at purchase and on future dividend growth, not on how many years the payout has been maintained. History is fixed; the multiple is reset every trading session.

Why does a premium valuation matter for a defensive stock?

A premium multiple assumes above-average certainty in future results. If growth slows or volumes decline, the shares can derate sharply, and a derating on a high multiple can erase several years of dividend income. Paying up for reliability means the buyer is not being compensated for that reliability, because the market has already priced it in.

How did Colgate-Palmolive perform against the broad market that day?

Colgate-Palmolive rose 0.87%, ahead of the S&P 500 proxy SPY at +0.54% and just behind the Dow 30 proxy DIA at +0.94%. The Nasdaq 100 proxy QQQ gained 0.46%, closing at $744.50. A single session says little about long-term merit but suggests staples were not being bid up as a defensive refuge.

Sources

• Colgate-Palmolive Has Paid a Dividend Since 1895. Does That Streak Still Deserves Your Money? — 24/7 Wall St